Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol
Lack of Processing Controls.
Yes — there is an active recall. 14 ongoing FDA recalls mention Niacinamide (30 total). Check the affected lots below.
Most common reason: Sterility / contamination (22 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Niacinamide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Presence of Particulate Matter.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility
Lack of assurance of sterility.
Lack of assurance of sterility.
Lack of Assurance of Sterility
Lack of Sterility Assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.